Abstract:Tau phosphorylation at specific Alzheimer's disease (AD)‐relevant epitopes negatively affects mitochondria, with the extent of dysfunction and stress response varying according to the sites of phosphorylation. ATP levels were reduced in cells expressing either tau pseudophosphorylated at S396/404 (2EC) or T231/S235 (2EM), and ROS production increased in 2EC cells during oxidation of succinate compared to wild type (T4)‐expressing cells. Thapsigargin reduced mitochondrial membrane potential (Ψm) and increased ROS production in both 2EC and 2EM cells. Altogether, these findings extend our understanding of potential mechanisms whereby phosphorylated tau promotes mitochondria dysfunction in tauopathies, including AD. The thickness of the green arrows corresponds with the magnitude of effect. The longer red and black arrows represent experiments conducted with stressors and in the basal state, respectively. Phosphorylation of tau at sites associated with Alzheimer's disease (AD) likely plays a role in the disease progression. Mitochondrial impairment, correlating with increased presence of phosphorylated tau, has been identified as a contributing factor to neurodegenerative processes in AD. However, how tau phosphorylated at specific sites impacts mitochondrial function has not been fully defined. We examined how AD‐relevant phosphomimetics of tau impact selected aspects of mitochondrial biology. To mimic phosphorylation at AD‐associated sites, the serine/threonine (Ser/Thr) sites in wild‐type green fluorescent protein (GFP)‐tagged tau (T4) were converted to glutamic acid (E) to make pseudo‐phosphorylated GFP‐tagged Ser‐396/404 (2EC) and GFP‐tagged Thr‐231/Ser‐235 (2EM) constructs. These constructs were expressed in immortalized mouse hippocampal neuronal cell lines, and their impact on specific mitochondrial functions and responses to stressors were measured. Phosphomimetic tau altered mitochondrial distribution. Specifically, mitochondria accumulated in the soma of cells expressing either 2EC or 2EM and neurite‐like extensions in 2EC cells were shorter. Additionally, adenosine triphosphate levels were reduced in both 2EC‐ and 2EM‐expressing cells, and reactive oxygen species (ROS) production increased in 2EC cells during oxidation of succinate when compared to T4‐expressing cells. Thapsigargin reduced mitochondrial membrane potential and increased ROS production in both 2EC and 2EM cells relative to T4 cells, with no significant difference in the effects of rotenone. These results show that tau phosphorylation at specific AD‐relevant epitopes negatively affects mitochondria, with the extent of dysfunction and stress response varying according to the sites of phosphorylation. Altogether, these findings show that phosphorylated tau increases mitochondrial susceptibility to stressors and extend our understanding of potential mechanisms whereby phosphorylated tau promotes mitochondria dysfunction in tauopathies, including AD.

Locus coeruleus vulnerability to tau hyperphosphorylation in a rat model

Defects in the autophagy lysosomal pathway in a cell model of disease‐associated tau

Consequences of Pathogenic Tau Expression in Mouse Locus Coeruleus

Spatiotemporal Assessment of Locus Coeruleus Integrity Predicting Cortical Tau and Cognition

Tau pathology spread in PS19 tau transgenic mice following locus coeruleus (LC) injections of synthetic tau fibrils is determined by the LC’s afferent and efferent connections

Novelty‐like activation of locus coeruleus protects against deleterious human pretangle tau effects while stress‐inducing activation worsens its effects

Locus coeruleus tau is linked to successive cortical tau accumulation

Tau pathology epigenetically remodels the neuron-glial cross-talk in Alzheimer's disease

Hyperphosphorylated Human Tau Accumulates at the Synapse, Localizing on Synaptic Mitochondrial Outer Membranes and Disrupting Respiration in a Mouse Model of Tauopathy

Perineuronal net deglycosylation associates with tauopathy‐induced gliosis and neurodegeneration

Tau‐mediated synaptic dysfunction is coupled with HCN channelopathy

Long-Term Depression-Inducing Low Frequency Stimulation Enhances p-Tau181 and p-Tau217 in an Age-Dependent Manner in Live Rats

Tau Modulates mRNA Transcription, Alternative Polyadenylation Profiles of hnRNPs, Chromatin Remodeling and Spliceosome Complexes

Protein tau phosphorylation in the proline rich region and its implication in the progression of Alzheimer's disease

Tau P301L disengages from the proteosome core complex and neurogranin coincident with enhanced neuronal network excitability

Locus coeruleus metabolic changes as a predictor of tau accumulation and cognitive decline

Acetylated Tau Obstructs KIBRA-Mediated Signaling in Synaptic Plasticity and Promotes Tauopathy-Related Memory Loss

Expression of P301L-hTau in Mouse MEC Induces Hippocampus-Dependent Memory Deficit

Convergence of presenilin- and tau-mediated pathways on axonal trafficking and neuronal function.

Abnormal tau induces cognitive impairment through two different mechanisms: synaptic dysfunction and neuronal loss

Site‐specific phosphorylation of tau impacts mitochondrial function and response to stressors